The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Integrating Bispecific Antibodies Into Clinical Practice
Integrating Bispecific Antibodies Into Clinical Practice
Clinical Challenges With Triple-Class or Penta-Refractory MM
Clinical Challenges With Triple-Class or Penta-Refractory MM
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
